Drug-induced hypersensitivity syndromes are associated with a variety of different drugs and have been recognized for many years. In previous studies and case reports, we usually defined the syndrome as a triad of fever, skin rash, and single or multiple internal organ involvement that starts within 8 weeks after initiation of therapy.1-4 However, the variable presentation with a wide variety of abnormal clinical and laboratory manifestations and the multitude of different synonyms used to describe this entity can make diagnosis or a literature search difficult and may contribute to the general unfamiliarity that physicians seem to have with this syndrome.
Schlienger RG, Shear NH. DIDMOHS: A Proposed Consensus Nomenclature for the Drug-Induced Delayed Multiorgan Hypersensitivity Syndrome—Reply. Arch Dermatol. 1998;134(7):876. doi:https://doi.org/
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: